Replies to post #13706 on Sorrento Therapeutics Inc (SRNE)

[1776club]

Looks like the pipeline collapsed.

[runcaly]

A LOT in the S-4 filing...few quick takes:

Page 117: SP-102/SEMDEXA is projecting revenue of $24ML in 2022?? what does that suggest...duh !! :) $193ML in 2023; $669ML in 2024, etc...and these are conservative lowball numbers !!!

Page 215, SEMDEXA commercial production will be supplied by Lifecore (existing trial supplier) and Sanofi. Interestingly, SRNE is currently suing Sanofi re: ZTlido (exhibit F-45)

SRNE $45ML Feb. loan explained !!! SRNE advanced $35ML in a loan to Scilex to allow Scilex to repurchase $20ML note...